FIGURE 5.
Results from overall survival (OS) analysis comparing the survival time of breast cancer patients with and without the mutation X17.7674220_C.T. The difference between the two groups of patients (with and without the mutation) is significant among young (under 45 years of age) individuals (p-value = 0.018), but not significant in older patients (p-value = 0.98).